Suchergebnisse
Silence Therapeutics plc ADR
WKN: A2QB4J / Symbol: SLN / Name: Silence Therapeutics / Aktie / Mid Cap /
12,20 €
-0,81 %
Silence Therapeutics’ Divesiran Hits Phase II Goal, Sets Up Phase III PV Trial
Key Points
- Interested in Silence Therapeutics PLC Sponsored ADR? Here are five stocks we like better.
- Divesiran met the Phase II SANRECO primary endpoint in phlebotomy-dependent polycythemia
Wall Street Analysts Predict a 140.06% Upside in Silence Therapeutics (SLN): Here's What You Should Know
Silence Therapeutics PLC Sponsored ADR (SLN) closed the last trading session at $13.58, gaining 30% over the past four weeks, but there could be plenty of upside left in the stock if short-term
